Researchers sought to identify disparities in the care and outcomes of patients with IBD of differing races and ethnicities, in order to improve health care equity.
Study authors assessed registry data to evaluate the risk of developing childhood chronic inflammatory diseases dependent on disease status of the parents.
Researchers state surgery should be considered for patients who demonstrate an inadequate response to medical therapy.
Authors say patients with hidradenitis suppurativa should be screened for inflammatory bowel disease.
Evidence insufficient for recommending changes in diet for complex carbs, refined sugars, wheat, gluten.
For both patients with ulcerative colitis and those with Crohn disease, psychiatric diagnoses were more common in those who were elderly (greater than 65 years old), women, and white, and those with psychiatric conditions more frequently had a history of alcohol abuse, tobacco and substance abuse, personality disorder, and corticosteroid use.
Treatment with anti-TNFα agents for conditions other than inflammatory bowel disease may increase the risk of developing Crohn disease or ulcerative colitis.
In older patients with inflammatory bowel disease, tumor necrosis factor alpha antagonist therapy and vedolizumab were found to be comparable with regard to both safety and effectiveness.
Patients with Crohn disease were enrolled in a comparative cohort study that analyzed the outcomes of reference product infliximab vs biosimilar treatment.
Women with Crohn disease who use oral contraceptives for more than 1 year have an increased risk of surgery.
